Sorafenib-Loaded PLGA-TPGS Nanosystems Enhance Hepatocellular Carcinoma Therapy Through Reversing P-Glycoprotein-Mediated Multidrug Resistance
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sorafenib-Loaded PLGA-TPGS Nanosystems Enhance Hepatocellular Carcinoma Therapy Through Reversing P-Glycoprotein-Mediated Multidrug Resistance
Authors
Keywords
-
Journal
AAPS PHARMSCITECH
Volume 23, Issue 5, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-04-30
DOI
10.1208/s12249-022-02214-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A meta-analysis of the efficacy and safety of adjuvant sorafenib for hepatocellular carcinoma after resection
- (2021) Shenglan Huang et al. World Journal of Surgical Oncology
- Preparation, evaluation and metabolites study in rats of novel amentoflavone-loaded TPGS/soluplus mixed nanomicelles
- (2020) Xue Feng et al. DRUG DELIVERY
- Dual P-Glycoprotein and CA XII Inhibitors: A New Strategy to Reverse the P-gp Mediated Multidrug Resistance (MDR) in Cancer Cells
- (2020) Elisabetta Teodori et al. MOLECULES
- Recent Advances of D-α-tocopherol Polyethylene Glycol 1000 Succinate Based Stimuli-responsive Nanomedicine for Cancer Treatment
- (2020) Yang Guan et al. Current Medical Science
- Lenvatinib for hepatocellular carcinoma: From preclinical mechanisms to anti-cancer therapy
- (2020) Yan Zhao et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Enhanced cellular uptake and cytotoxicity of vorinostat through encapsulation in TPGS-modified liposomes
- (2020) Muhammad Asim Farooq et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Atalantums H-K from the peels of Atalantia monophylla and their cytotoxicity
- (2019) Aonnicha Sombatsri et al. NATURAL PRODUCT RESEARCH
- Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance
- (2019) Meng Lei et al. DRUG DELIVERY
- Current status of nanomaterial-based treatment for hepatocellular carcinoma
- (2019) Badriya Baig et al. BIOMEDICINE & PHARMACOTHERAPY
- Dihydroartemisinin and doxorubicin co-loaded Soluplus®-TPGS mixed micelles: formulation characterization, cellular uptake, and pharmacodynamic studies
- (2019) Yutong Wang et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice
- (2019) Elena Tirrò et al. Genes
- Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC
- (2019) Lai Wei et al. Nature Communications
- Development and evaluation of a novel drug delivery: Soluplus®/TPGS mixed micelles loaded with piperine in vitro and in vivo
- (2018) Yingying Ding et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- P-gp is involved in the intestinal absorption and biliary excretion of afatinib in vitro and in rats
- (2018) Yan Zhang et al. Pharmacological Reports
- Kanglaite reverses multidrug resistance of HCC by inducing apoptosis and cell cycle arrest via PI3K/AKT pathway
- (2018) Chendong Yang et al. OncoTargets and Therapy
- Improved biopharmaceutical properties of carvedilol employing α-tocopheryl polyethylene glycol 1000 succinate-based self-emulsifying drug delivery system
- (2018) Shimul Halder et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Therapeutic Effect of Sorafenib-Loaded TPGS-b-PCL Nanoparticles on Liver Cancer
- (2018) Xiaolong Tang et al. Journal of Biomedical Nanotechnology
- Galactosylated chitosan Triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms
- (2018) Yan-Qiong Zhang et al. Nanomedicine-Nanotechnology Biology and Medicine
- Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
- (2017) Deepali Waghray et al. JOURNAL OF MEDICINAL CHEMISTRY
- Paclitaxel-Loaded TPGS-b-PCL Nanoparticles: In Vitro Cytotoxicity and Cellular Uptake in MCF-7 and MDA-MB-231 Cells versus mPEG-b-PCL Nanoparticles and Abraxane®
- (2016) Ezequiel Bernabeu et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- Solid lipid nanoparticles with TPGS and Brij 78: A co-delivery vehicle of curcumin and piperine for reversing P-glycoprotein-mediated multidrug resistance in vitro
- (2016) Jingling Tang et al. Oncology Letters
- Development of sorafenib-related side effects in patients diagnosed with advanced hepatocellular carcinoma treated with sorafenib: a systematic-review and meta-analysis of the impact on survival
- (2016) Omar Abdel-Rahman et al. Expert Review of Gastroenterology & Hepatology
- Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance
- (2015) Tangna Hao et al. ACS Applied Materials & Interfaces
- The Adverse Effects of Sorafenib in Patients with Advanced Cancers
- (2015) Ye Li et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Enhanced toxicity and cellular uptake of methotrexate-conjugated nanoparticles in folate receptor-positive cancer cells by decorating with folic acid-conjugated d -α-tocopheryl polyethylene glycol 1000 succinate
- (2015) Varaporn Buraphacheep Junyaprasert et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Co-delivery of docetaxel and Poloxamer 235 by PLGA–TPGS nanoparticles for breast cancer treatment
- (2015) Xiaolong Tang et al. Materials Science & Engineering C-Materials for Biological Applications
- Effects of P-Glycoprotein and Its Inhibitors on Apoptosis in K562 Cells
- (2014) Yaqiong Zu et al. MOLECULES
- Design and in vitro evaluation of a novel polymeric P-glycoprotein (P-gp) inhibitor
- (2010) Javed Iqbal et al. JOURNAL OF CONTROLLED RELEASE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started